[Endovascular treatment of patients suffering from multifocal atherosclerosis in a clinic without cardiovascular
Insights
This study details diagnosing multifocal atherosclerosis in major arteries. Endovascular treatment proved safe and effective for patients without needing cardiac surgery support.
Area of Science:
- Vascular Medicine
- Diagnostic Imaging
- Interventional Cardiology
Background:
- Multifocal atherosclerosis affects multiple arterial beds, increasing cardiovascular risk.
- Comprehensive diagnosis is crucial for effective management.
- Endovascular techniques offer minimally invasive treatment options.
Purpose of the Study:
- To outline current clinical and radiological diagnostic approaches for multifocal atherosclerosis.
- To evaluate the efficacy and safety of endovascular treatment in a non-cardiosurgical setting.
Main Methods:
- Review of current diagnostic strategies for multifocal atherosclerosis.
- Analysis of clinical outcomes and safety data for endovascular interventions.
- Focus on involvement of coronary, renal, brachiocephalic, and lower limb arteries.
Main Results:
- Multifocal atherosclerosis diagnosis integrates clinical assessment and advanced radiological imaging.
- Endovascular treatment demonstrated significant clinical efficacy.
- The procedures were performed safely without requiring cardiosurgical backup.
Conclusions:
- Integrated clinical and radiological diagnosis is essential for multifocal atherosclerosis.
- Endovascular therapy is a viable and safe option for multifocal atherosclerosis, even in facilities without immediate cardiosurgical capabilities.
Abstract:
The article reflects the present-day aspects concerning comprehensive clinical and radiological diagnosis of multifocal atherosclerosis with the involvement of the coronary, renal, brachiocephalic arteries and arteries of the lower limbs. Confirmed herein is clinical efficacy and safety of endovascular treatment for multifocal atherosclerosis in a clinical hospital without cardiosurgical support.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...